CONFERENCES

      APOE and Immunity Conference

      This is an annual conference that focuses on the role of APOE (apolipoprotein E) and immunity in Alzheimer's disease, with topics ranging from genetics to immunotherapy. The conference is aimed at researchers, clinicians, and other professionals involved in the study and treatment of Alzheimer's disease, and provides an opportunity to share knowledge and collaborate on new approaches to therapy.

      APOE and Immunity 2021

      Date

      Oct 18, 2021 - Oct 21, 2021

      Location

      Online

      This conference presents the latest research on the roles of APOE, neuroinflammation, and innate and adaptive immunity in neurodegenerative diseases like Alzheimer’s and other dementias. 

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.